Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06317220
PHASE2

Vedolizumab for the Treatment of Collagenous Gastritis

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn about how vedolizumab may affect patients with collagenous gastritis (CG). The main questions it aims to answer are: * Whether vedolizumab can reduce CG symptoms * Whether vedolizumab is safe to take for patients with CG Participants in this study will: * Receive vedolizumab through an IV ("infusion") * Complete a survey at each infusion visit * Have blood collected at each infusion visit * Undergo an endoscopy with biopsy at 2 timepoints

Key Details

Gender

All

Age Range

14 Years - Any

Study Type

INTERVENTIONAL

Enrollment

11

Start Date

2024-12-03

Completion Date

2026-10

Last Updated

2025-12-17

Healthy Volunteers

No

Interventions

BIOLOGICAL

Vedolizumab

Administered over 30 minute infusion at MGH main campus

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States